Nautilus Biotechnology, Inc.
Index- P/E- EPS (ttm)-0.47 Insider Own8.20% Shs Outstand124.79M Perf Week13.30%
Market Cap285.87M Forward P/E- EPS next Y-0.76 Insider Trans0.44% Shs Float90.46M Perf Month4.55%
Income-57.90M PEG- EPS next Q-0.17 Inst Own45.50% Short Float / Ratio0.99% / 6.39 Perf Quarter46.50%
Sales- P/S- EPS this Y-14.90% Inst Trans-1.78% Short Interest0.89M Perf Half Y9.52%
Book/sh2.52 P/B0.91 EPS next Y0.00% ROA-15.80% Target Price5.00 Perf Year-43.35%
Cash/sh1.48 P/C1.55 EPS next 5Y- ROE-17.50% 52W Range1.50 - 5.07 Perf YTD27.78%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-54.59% Beta-
Dividend %- Quick Ratio27.60 Sales past 5Y- Gross Margin- 52W Low53.33% ATR0.15
Employees134 Current Ratio27.60 Sales Q/Q- Oper. Margin- RSI (14)61.03 Volatility8.59% 7.68%
OptionableYes Debt/Eq0.00 EPS Q/Q20.00% Profit Margin- Rel Volume2.73 Prev Close2.26
ShortableYes LT Debt/Eq0.00 EarningsFeb 23 BMO Payout- Avg Volume139.83K Price2.30
Recom2.20 SMA208.34% SMA5013.73% SMA2001.82% Volume381,563 Change1.77%
Jan-06-22Initiated Morgan Stanley Equal-Weight $8
Nov-02-21Initiated Cowen Outperform
Aug-04-21Initiated Goldman Neutral $10
Jul-13-21Initiated Jefferies Buy $13
Mar-07-23 08:00AM
Feb-23-23 06:05AM
Feb-21-23 08:00AM
Jan-26-23 08:00AM
08:00AM Loading…
Jan-19-23 08:00AM
Nov-16-22 08:00AM
Nov-01-22 06:05AM
Oct-05-22 08:00AM
Sep-23-22 08:00AM
Sep-01-22 08:00AM
Aug-30-22 08:00AM
Aug-11-22 06:30AM
Aug-02-22 06:48AM
Aug-01-22 04:05PM
08:00AM Loading…
Jul-13-22 08:00AM
May-12-22 06:28AM
May-03-22 06:00AM
Apr-12-22 08:00AM
Apr-07-22 08:00AM
Apr-04-22 08:00AM
Mar-31-22 04:05PM
Mar-05-22 07:22AM
Feb-24-22 06:00AM
Feb-16-22 04:05PM
Feb-02-22 01:38PM
Jan-27-22 08:00AM
Dec-16-21 01:07PM
Dec-05-21 06:39AM
Nov-02-21 08:00AM
08:00AM Loading…
Oct-11-21 08:00AM
Sep-10-21 10:21AM
Sep-03-21 09:00AM
Aug-10-21 06:00AM
Aug-09-21 08:00AM
Jul-13-21 08:00AM
Jun-17-21 07:00AM
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was incorporated in 2016 and is headquartered in Seattle, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sankar SubramanianSenior VP, Product DevelopmentSep 27Buy2.035,00010,14991,250Sep 28 04:01 PM
Sankar SubramanianSenior VP, Product DevelopmentSep 26Buy2.0210,00020,25086,250Sep 28 04:01 PM
Weld Gwen EChief People OfficerSep 23Buy2.0330,00060,76530,000Sep 26 09:26 PM
Sankar SubramanianSenior VP, Product DevelopmentSep 16Buy2.1635,00075,44675,000Sep 19 05:50 PM
Sankar SubramanianSenior VP, Product DevelopmentSep 15Buy2.1940,00087,75240,000Sep 19 05:50 PM
Mowry AnnaCFO and TreasurerAug 19Buy2.3017,50040,21856,750Aug 22 07:40 PM
Murphy Matthew B.General CounselAug 15Buy2.847,50021,30854,140Aug 16 08:19 PM
Murphy Matthew B.General CounselAug 12Buy2.852,5007,12546,640Aug 16 08:19 PM
Patel Sujal MCEO, President, and SecretaryAug 08Buy2.938,34624,44410,014,488Aug 08 07:48 PM
Patel Sujal MCEO, President, and SecretaryAug 05Buy2.9241,654121,64610,006,142Aug 08 07:48 PM
Mowry AnnaCFO and TreasurerJun 27Buy2.755,50015,12439,250Jun 28 06:17 PM
Patel Sujal MCEO, President, and SecretaryMay 09Buy3.9650,000198,0009,964,488May 10 08:28 PM